Publications by authors named "Sami Hammi"
Article Synopsis
- Pernicious anemia (PA) causes difficulty in absorbing vitamin B12 due to a lack of intrinsic factor, leading to the standard treatment of intramuscular injections, though oral supplementation has potential.
- This study evaluated the effectiveness of oral vitamin B12 supplementation on patients diagnosed with PA by measuring various plasma and urinary vitamin B12-related biomarkers over one year.
- Results revealed that after one month of oral supplementation, 88.5% of participants were no longer deficient in vitamin B12, with significant and sustained improvements in relevant biomarkers throughout the study, indicating oral supplementation may be a viable treatment option.
Background: It is unclear whether hereditary hemorrhagic telangiectasia (HHT) patients can tolerate antithrombotic therapies (AT) including antiplatelet (AP) and/or anticoagulant (AC) agents.
Objectives: Primary endpoint was tolerance to AT in HHT. Secondary endpoints were to identify factors associated with major bleeding events (MBE) and premature discontinuation of AT.